MRNA Operating Cash Flow (Statement)
-$1.05BTTM · USD
Period ending:
MRNA FY Cash from OperationsUSD
$13.62B-$3.12B
2016-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
MRNA operating cash flow (statement) history
Net cash provided by operating activities. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -1,873,000,000 | |
| -3,004,000,000 | |
| -3,118,000,000 | |
| 4,981,000,000 | |
| 13,620,000,000 | |
| 2,026,971,000 | |
| -458,968,000 | |
| -330,865,000 | |
| -331,484,000 | |
| 66,734,000 |
Compare operating cash flow (statement)
All MRNA financial metrics · MRNA stock overview · How to interpret financial metrics
